Complement activation at the interface between adipocytes and cancer cells drives tumor progression

Valdivia, Andres; Isac, Ana Maria; Cardenas, Horacio; Zhao, Guangyuan; Zhang, Yaqi; Huang, Hao; Wei, Jian-Jun; Cuello-Fredes, Mauricio; Kato, Sumie; Gomez-Valenzuela, Fernan; Gourronc, Francoise; Klingelhutz, Aloysius; Matei, Daniela

Abstract

The omentum is the primary site of metastasis for ovarian cancer (OC). Interactions between cancer cells and adipocytes drive an invasive and prometastatic phenotype. Here we studied cancer cell- adipocyte crosstalk by using a direct coculture model with immortalized human visceral nondiabetic pre-adipocytes (VNPADs) and OC cells. We demonstrated increased proliferation, invasiveness, and resistance to cisplatin of cocultured compared with monocultured OC cells. RNA sequencing of OC cells from coculture versus monoculture revealed significant transcriptomic changes, identifying over 200 differentially expressed genes common to OVCAR5 and OVCAR8 cell lines. Enriched pathways included PI3K/AKT and complement activation. Lipid transfer into OC cells from adipocytes induced upregulation of complement C3 and C5 proteins. Inhibiting C3 or C5 reversed the invasive phenotype and C3 knockdown reduced tumor progression in vivo. Increased C3 expression was observed in omental implants compared with primary ovarian tumors and C3 secretion was higher in OC ascites from high-BMI versus low-BMI patients. C3 upregulation in OC cells involved activation of the ATF4-mediated integrated stress response (ISR). Overall, adipocyte-cancer cell interactions promoted invasiveness and tumorigenesis via lipid transfer, activating the ISR, and upregulating complement proteins C3 and C5.

Más información

Título según WOS: ID WOS:001452442800001 Not found in local WOS DB
Título de la Revista: JCI INSIGHT
Volumen: 10
Número: 6
Editorial: AMER SOC CLINICAL INVESTIGATION INC
Fecha de publicación: 2025
DOI:

10.1172/jci.insight.184935

Notas: ISI